Cryolife reported $75.27M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US USD 8.76B 123M
Angiodynamics ANGO:US USD 93.54M 1.29M
Atricure ATRC:US USD 92.16M 1.8M
Baxter International BAX:US USD 3.7B 2.88B
Becton, Dickinson and BDX:US USD 4B 293M
Boston Scientific BSX:US USD 2.84B 28M
Cardiovascular Systems CSII:US USD 69.98M 594K
Cryolife CRY:US USD 75.27M 5.68M
Edwards Lifesciences EW:US USD 900.5M 16.1M
Inogen INGN:US USD 146.58M 30.9M
Integra Lifesciences IART:US USD 337.52M 18.7M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Mesa Laboratories MLAB:US USD 50.88M 3.87M
Orthofix International OFIX:US USD 133.27M 13.49M
Pfizer PFE:US USD 19.12B 5.9B
Resmed RMD:US USD 753.55M 78.99M
Stryker SYK:US USD 4.39B 717M
Surmodics SRDX:US USD 32.16M 439K
Tandem Diabetes Care TNDM:US USD 238.28M 13.76M
Teleflex TFX:US USD 629.86M 75.52M
Terumo 4543:JP JPY 177.14B 3.29B